Discover 1,248 paid clinical trials in Nashville, Tennessee. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Nashville offers many research opportunities for conditions such as diabetes, cardiovascular disease, and arthritis, giving participants access to innovative treatments and cutting-edge medical care. The city’s leading healthcare institutions are actively recruiting healthy volunteers for paid research studies, as well as individuals seeking trials for specific health concerns.
Filter
2
Filter results
Results: 1,248
Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease
for
cGVHD
Location: Nashville TN, Birmingham AL, Atlanta GA, Augusta GA,
Sponsor: Incyte Corporation
Sex: All
Age: 18+
Code: NCT05919511
Recruiting
Pounce™ Thrombectomy System Retrospective Registry
for
Peripheral Arterial Disease, Acute Limb Ischemia
Location: Nashville TN, Greenville SC, Peoria IL, Cleveland OH,
Sponsor: SurModics, Inc.
Sex: All
Age: 18+
Code: NCT05868161
Recruiting
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
for
Hematologic Disorder, Bleeding Disorder,
Location: Nashville TN, Memphis TN, Atlanta GA, Cincinnati OH,
Sponsor: American Thrombosis and Hemostasis Network
Sex: All
Age: 0+
Code: NCT04398628
Recruiting
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort C: Bevacizumab
for
Acute Respiratory Distress Syndrome (ARDS), ARDS,
Location: Nashville TN, Peoria IL, Toledo OH, Chapel Hill NC,
Sponsor: PPD Development, LP
Sex: All
Age: 18+
Code: NCT06701656
Phase2, Recruiting
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort B: Paridiprubart
for
Acute Respiratory Distress Syndrome (ARDS), ARDS,
Location: Nashville TN, Peoria IL, Toledo OH, Chapel Hill NC,
Sponsor: PPD Development, LP
Sex: All
Age: 18+
Code: NCT06701669
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Onyx™ Liquid Embolic IDE Clinical Study
for
Peripheral Arterial Hemorrhage, Trauma, GI Bleed, Ulcer,
Location: Nashville TN, Columbus OH, Chicago IL, Chapel Hill NC,
Sponsor: Medtronic Endovascular
Sex: All
Age: 22+
Code: NCT06742801
Recruiting
Monitoring and Adjustment of Medication Therapy for Patients With Heart Disease
for
Coronary Heart Disease, Myocardial Infarction
Location: Nashville TN
Sponsor: Middle Tennessee Research Institute
Sex: All
Age: 60 - 70+
Code: NCT01427218
Recruiting
Empagliflozin Treatment in Kidney Transplant Recipients
for
Kidney Transplant, Chronic Kidney Disease
Location: Nashville TN, Hines IL, Iowa City IA, Pittsburgh PA,
Sponsor: VA Office of Research and Development
Sex: All
Age: 19+
Code: NCT06013865
Recruiting
Improving Veteran Referral to Cardiac Rehabilitation
for
Cardiovascular Disease, Cardiac Rehabilitation
Location: Nashville TN, Gainesville FL, Dallas TX
Sponsor: VA Office of Research and Development
Sex: All
Age: 18+
Code: NCT07079358
Recruiting
Randomized Clinical Trial for Ewing Amputation in the VA
for
Peripheral Arterial Disease
Location: Nashville TN, Decatur GA, Houston TX
Sponsor: VA Office of Research and Development
Sex: All
Age: 0+
Code: NCT05437562
Recruiting
A Study to Improve Skeletal Muscle in Veterans With HIV
for
HIV, Obesity
Location: Nashville TN
Sponsor: VA Office of Research and Development
Sex: Male
Age: 20 - 70+
Code: NCT06845046
Recruiting
Combining a Smartphone App With Medications to Manage Heavy Drinking
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
for
Ovarian Cancer, Fallopian Tube Cancer,
Location: Nashville TN, Birmingham AL, Atlanta GA, Cincinnati OH,
Sponsor: Merck Sharp & Dohme LLC
Sex: Female
Age: 18+
Code: NCT06824467
Phase3, Recruiting
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
Location: Nashville TN, Atlanta GA, St Louis MO, Columbus OH,
Sponsor: Pierre Fabre Medicament
Sex: All
Age: 0+
Code: NCT03394365
Phase3, Recruiting
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
Study Evaluating the Efficacy of KITE-753 Versus Axicabtagene Ciloleucel in Participants With Relapsed or Refractory Large B-Cell Lymphoma After First-Line Therapy
for
Relapsed or Refractory Large B-cell Lymphoma
Location: Nashville TN, Newnan GA, St Louis MO, Charlotte NC,
Sponsor: Kite, A Gilead Company
Sex: All
Age: 18+
Code: NCT07479797
Phase3, Recruiting
A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)